|
AYTU
Aytu Biopharma, Inc
AYTU · Q1 FY2023
|
Q1 FY2023 |
|
AYTU Q1 FY2023 transcript
|
|
INUV
Inuvo, Inc.
INUV · Q3 FY2022
|
Q3 FY2022 |
|
INUV Q3 FY2022 transcript
|
|
IPW
iPower Inc.
IPW · Q1 FY2023
|
Q1 FY2023 |
|
IPW Q1 FY2023 transcript
|
|
GETY
Getty Images Holdings, Inc.
GETY · Q3 FY2022
|
Q3 FY2022 |
|
GETY Q3 FY2022 transcript
|
|
XAIR
Beyond Air, Inc.
XAIR · Q2 FY2023
|
Q2 FY2023 |
|
XAIR Q2 FY2023 transcript
|
|
ACM
Aecom
ACM · Q4 FY2022
|
Q4 FY2022 |
|
ACM Q4 FY2022 transcript
|
|
PLX
Protalix BioTherapeutics, Inc.
PLX · Q3 FY2022
|
Q3 FY2022 |
|
PLX Q3 FY2022 transcript
|
|
AIRI
Air Industries Group
AIRI · Q3 FY2022
|
Q3 FY2022 |
|
AIRI Q3 FY2022 transcript
|
|
VNRX
Volitionrx Ltd
VNRX · Q3 FY2022
|
Q3 FY2022 |
|
VNRX Q3 FY2022 transcript
|
|
CMCT
Creative Media & Community Trust Corp
CMCT · Q3 FY2022
|
Q3 FY2022 |
|
CMCT Q3 FY2022 transcript
|
|
AZTA
Azenta, Inc.
AZTA · Q4 FY2022
|
Q4 FY2022 |
|
AZTA Q4 FY2022 transcript
|
|
SMTI
Sanara MedTech Inc.
SMTI · Q3 FY2022
|
Q3 FY2022 |
|
SMTI Q3 FY2022 transcript
|
|
NGS
Natural Gas Services Group Inc
NGS · Q3 FY2022
|
Q3 FY2022 |
|
NGS Q3 FY2022 transcript
|
|
BFRI
Biofrontera Inc.
BFRI · Q3 FY2022
|
Q3 FY2022 |
|
BFRI Q3 FY2022 transcript
|
|
PATH
UiPath, Inc.
PATH · Q3 FY2023
|
Q3 FY2023 |
|
PATH Q3 FY2023 transcript
|
|
TDUP
ThredUp Inc.
TDUP · Q3 FY2022
|
Q3 FY2022 |
|
TDUP Q3 FY2022 transcript
|
|
LGVN
Longeveron Inc.
LGVN · Q3 FY2022
|
Q3 FY2022 |
|
LGVN Q3 FY2022 transcript
|
|
CIFR
Cipher Digital Inc.
CIFR · Q3 FY2022
|
Q3 FY2022 |
|
CIFR Q3 FY2022 transcript
|
|
LGMK
LogicMark, Inc.
LGMK · Q3 FY2022
|
Q3 FY2022 |
|
LGMK Q3 FY2022 transcript
|
|
IONS
Ionis Pharmaceuticals Inc
IONS · Q3 FY2022
|
Q3 FY2022 |
|
IONS Q3 FY2022 transcript
|
|
EGAN
EGAIN Corp
EGAN · Q1 FY2023
|
Q1 FY2023 |
|
EGAN Q1 FY2023 transcript
|
|
AP
Ampco Pittsburgh Corp
AP · Q3 FY2022
|
Q3 FY2022 |
|
AP Q3 FY2022 transcript
|
|
REI
Ring Energy, Inc.
REI · Q3 FY2022
|
Q3 FY2022 |
|
REI Q3 FY2022 transcript
|
|
DNA
Ginkgo Bioworks Holdings, Inc.
DNA · Q3 FY2022
|
Q3 FY2022 |
|
DNA Q3 FY2022 transcript
|